Healthcare provider profile · identity verified

Alexandra E Moody, MD

Internal Medicine · HARRISBURG, PA · NPI 1578054169

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	576	172
Levothyroxine Sodium	Levothyroxine Sodium	327	98
Lisinopril	Lisinopril	324	92
Losartan Potassium	Losartan Potassium	283	77
Amlodipine Besylate	Amlodipine Besylate	253	67
Omeprazole	Omeprazole	240	68
Rosuvastatin Calcium	Rosuvastatin Calcium	197	60
Simvastatin	Simvastatin	182	51
Gabapentin	Gabapentin	178	44
Hydrochlorothiazide	Hydrochlorothiazide	177	47
Metoprolol Succinate	Metoprolol Succinate	170	56
Metformin Hcl	Metformin Hcl	156	47
Pantoprazole Sodium	Pantoprazole Sodium	113	31
Duloxetine Hcl	Duloxetine Hcl	105	28
Eliquis	Apixaban	102	21
Famotidine	Famotidine	102	25
Synthroid	Levothyroxine Sodium	93	28
Sertraline Hcl	Sertraline Hcl	92	22
Pravastatin Sodium	Pravastatin Sodium	88	25
Escitalopram Oxalate	Escitalopram Oxalate	86	22
Trazodone Hcl	Trazodone Hcl	83	24
Fluoxetine Hcl	Fluoxetine Hcl	80	19
Metoprolol Tartrate	Metoprolol Tartrate	78	24
Lorazepam	Lorazepam	75	26
Carvedilol	Carvedilol	72	20
Fluticasone Propionate	Fluticasone Propionate	72	25
Tramadol Hcl	Tramadol Hcl	72	24
Bupropion Xl	Bupropion Hcl	71	17
Meloxicam	Meloxicam	68	19
Alendronate Sodium	Alendronate Sodium	67	23
Metformin Hcl Er	Metformin Hcl	62	24
Furosemide	Furosemide	61	24
Tamsulosin Hcl	Tamsulosin Hcl	59	13
Alprazolam	Alprazolam	58	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	17
Zolpidem Tartrate	Zolpidem Tartrate	54	16
Montelukast Sodium	Montelukast Sodium	53	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Spironolactone	Spironolactone	51	11
Citalopram Hbr	Citalopram Hydrobromide	49	14
Ezetimibe	Ezetimibe	48	18
Jardiance	Empagliflozin	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	45	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	20
Atenolol	Atenolol	44	14
Paroxetine Hcl	Paroxetine Hcl	44	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	suppressed
Irbesartan	Irbesartan	39	12
Venlafaxine Hcl Er	Venlafaxine Hcl	39	11
Benazepril Hcl	Benazepril Hcl	38	13
Buspirone Hcl	Buspirone Hcl	38	12
Trulicity	Dulaglutide	35	suppressed
Clonazepam	Clonazepam	33	13
Allopurinol	Allopurinol	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Celecoxib	Celecoxib	28	suppressed
Ozempic	Semaglutide	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Glipizide	Glipizide	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Finasteride	Finasteride	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Lansoprazole	Lansoprazole	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Baclofen	Baclofen	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Fentanyl	Fentanyl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Prednisone	Prednisone	15	15
Propranolol Hcl	Propranolol Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Linzess	Linaclotide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ramipril	Ramipril	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error